Men or women ≥50 years of age with active subfoveal CNV secondary to AMD, including juxtafoveal lesions that affect the fovea as evidenced by FA in the study eye as assessed by a central reading center

BCVA ETDRS letter score of 73 to 24 (Snellen equivalent of 20/40 to 20/320) in the study eye.

Willing and able to comply with clinic visits and study-related procedures.

Provide signed informed consent.

Key Exclusion Criteria:

Evidence of CNV due to any cause other than AMD in either eye

Prior IVT anti-VEGF in the study eye

Evidence of DME or diabetic retinopathy (defined as more than 1 microaneurysm) in either eye in diabetic patients

Any history of macular hole of stage 2 and above in the study eye

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02713204